Is a
Clinical Study attributes
NCT Number
Trial Recruitment Size
30
Trial Sponsor
Trial Collaborator
Clinical Trial Start Date
2014
0Primary Completion Date
2018
0Study Completion Date
2018
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Biological0
Intervention Name
INO-3106, INO-90120
Interventional Trial Phase
Phase 10
Participating Facility
Official Name
A Study of HPV Specific Immunotherapy in Subjects With HPV6 Associated Aerodigestive Precancerous Lesions and Malignancies0
Last Updated
November 16, 2018
0Allocation Type
Non-Randomized0
Intervention Model
Single Group Assignment0
Masking Type
None (Open Label)0
Study summary
This is a Phase I, open-label study to evaluate the safety, tolerability, and immunogenicity of INO-3106 alone or in combination with INO-9012 DNA vaccines delivered by Electroporation to subjects with HPV6 associated aerodigestive precancerous lesions and malignancies.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
